Global Medical Silicone Radiopaque Vascular Ties Market Size, Share, and COVID-19 Impact Analysis, By Type (Occlusion Ties, Retracting Ties, and Marking Ties), By Application (Cardiovascular & Thoracic Surgery, Neurosurgery, General Surgery, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Medical Silicone Radiopaque Vascular Ties Market Insights Forecasts to 2035

• The Global Medical Silicone Radiopaque Vascular Ties Market Size Was Estimated at USD 40.8 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 3.23% from 2025 to 2035
• The Worldwide Medical Silicone Radiopaque Vascular Ties Market Size is Expected to Reach USD 57.9 Million by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

 According to a research report published by Spherical Insights and Consulting, the global medical silicone radiopaque vascular ties market size was worth around USD 40.8 million in 2024 and is predicted to grow to around USD 57.9 million by 2035 with a compound annual growth rate (CAGR) of 3.23% from 2025 to 2035. The worldwide market for silicone radiopaque vascular ties is expanding due to the surge in minimally invasive surgeries, the higher incidence of chronic cardiovascular conditions, and the ageing demographic.

Market Overview

The worldwide market for silicone radiopaque vascular ties refers to specialized silicone surgical ties that contain radiopaque substances, making them clearly visible in X-ray or fluoroscopic imaging. These tools are utilized to block, retract or mark blood vessels in cardiovascular, neurovascular and minimally invasive procedures, improving accuracy and safety. This market's growth is driven by an increase in procedures, a rising prevalence of chronic vascular diseases, and continuous improvements in silicone radiopacity and biocompatibility.

Opportunities emerge from the growing adoption of methods, the shift to single-use sterile surgical tools and increased healthcare investment in developing regions. Additionally, advancements in image-guided surgery create avenues for innovation. Leading firms in the industry include manufacturers of silicone components, vascular access instruments, and surgical equipment, such as Freudenberg Medical, Elkem Silicones, and Trelleborg Healthcare & Medical, alongside dedicated OEM/ODM medical device producers supplying radiopaque silicone parts for applications. In June 2025, the World Health Organization hosted its Global Forum on Medical Devices, bringing together regulators, industry leaders and healthcare specialists from than 130 nations. The event centred on enhancing access, safety, cost-effectiveness and technological progress by fostering cooperation to support devices such as radiopaque vascular ties.

Report Coverage

This research report categorizes the medical silicone radiopaque vascular ties market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the medical silicone radiopaque vascular ties market. Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the medical silicone radiopaque vascular ties market.

Driving Factors

The worldwide market for silicone radiopaque vascular ties is propelled by the increase in surgical procedures, especially in cardiovascular, neurovascular and minimally invasive surgeries that need exact vessel identification. The growing incidence of conditions like atherosclerosis and diabetes boosts the need for dependable vessel-management solutions. Innovations in silicone materials enhance imaging clarity and surgical security. The market expansion is also driven by the use of sterile equipment, regulatory emphasis on patient protection and the growth of healthcare facilities in developing regions. In October 2025, China's NMPA implemented the Measures to Optimize Life-Cycle Regulation, enabling quicker authorization and market introduction for advanced biomaterial-based devices, such as radiopaque silicone vascular ties.

Restraining Factors

The medical silicone radiopaque vascular ties market faces restraints, including high production costs, stringent regulatory approvals, and limited reimbursement policies. Technical challenges in maintaining radiopacity and flexibility, combined with competition from alternative vessel-management devices, slow adoption. Additionally, the lack of awareness among healthcare providers in emerging markets limits market expansion.

Market Segmentation

The medical silicone radiopaque vascular ties market is segmented based on type and application.

By type, the market is categorized into occlusion ties, retracting ties, and marking ties. Among these, the occlusion ties segment held the largest market share in 2024, accounting for approximately 45%, and is expected to witness substantial growth during the forecast period. The dominance of this segment is attributed to its critical role in regulating blood flow during surgical procedures, particularly in cardiovascular and thoracic surgeries. The radiopaque properties of occlusion ties enable precise visualization and placement under fluoroscopic guidance, enhancing surgical efficiency and safety.

Moreover, the rising incidence of cardiovascular conditions, coupled with advancements in minimally invasive surgical techniques, is driving the demand for reliable and effective vascular ties, further strengthening the market leadership of occlusion ties.

The cardiovascular & thoracic surgery segment accounted for the largest share of the medical silicone radiopaque vascular ties market in 2024, contributing approximately 40% of total revenue, and is expected to grow at a significant CAGR during the forecast period.

Based on application, the market is segmented into cardiovascular & thoracic surgery, neurosurgery, general surgery, and others, with cardiovascular & thoracic surgery emerging as the leading category. Growth in this segment is driven by the increasing prevalence of cardiovascular diseases and a rising number of thoracic procedures that require precise vascular management. Silicone radiopaque vascular ties—particularly occlusion ties—support enhanced blood flow control and improve surgical accuracy. Additionally, ongoing advancements in minimally invasive techniques and surgical technologies are anticipated to further boost demand for high-quality vascular ties, contributing to improved procedural safety and patient outcomes.

Regional Segment Analysis of the Medical Silicone Radiopaque Vascular Ties Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the medical silicone radiopaque vascular ties market over the predicted timeframe.

North America is anticipated to hold the largest share of the medical silicone radiopaque vascular ties market over the predicted timeframe. North America is expected to have a 38% market share of the medical silicone radiopaque vascular ties market, mainly led by the United States, which controls the area. The high number of surgeries in cardiovascular, thoracic and minimally invasive operations fuels significant demand for accurate vascular management instruments. Developed healthcare facilities, broad use of radiopaque products and supportive reimbursement frameworks additionally promote market expansion. Moreover, knowledge of safety, rigorous regulatory requirements and continuous advancements in silicone-based vascular ligatures support North America’s dominance in the worldwide market.

Asia Pacific is expected to grow at a rapid CAGR in the medical silicone radiopaque vascular ties market during the forecast period. Asia Pacific is projected to have a 20% market share growth in the medical silicone radiopaque vascular ties market, spearheaded by China and India. Growth is fueled by enhancements in healthcare infrastructure, an uptick in thoracic disease cases and a rise in surgical procedures. The uptake of surgical technologies, government efforts supporting local medical device manufacturing, and heightened patient safety awareness also contribute to the market's expansion. In October 2024, India’s CDSCO became a member of the International Medical Device Regulators Forum (IMDRF), harmonizing its regulations with standards and improving the quality, safety and global market availability of Indian medical devices.

Europe’s medical silicone radiopaque vascular ties market is driven by Germany, France, and the UK, supported by advanced healthcare systems, high surgical volumes, and early adoption of innovative devices. Rising cardiovascular and thoracic disease prevalence and strict regulations boost demand for precise vascular management. Technological advances in minimally invasive surgeries further expand the market. In July 2025, the UK’s MHRA proposed reforms to simplify approvals for innovative devices, reduce regulatory duplication, and accelerate market access for novel medical technologies.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the medical silicone radiopaque vascular ties market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Batrik Medical Manufacturing
• Vecmedical
• Argon Medical Devices
• BOENMED
• Freudenberg Medical
• Trelleborg Healthcare & Medical
• Elkem Silicones
• Terumo
• B. Braun Melsungen AG
• Merit Medical Systems
• Integra LifeSciences
• Cardiva Medical Inc.
• Teleflex Incorporated
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In October 2025, Elkem ASA unveiled SILBIONE LSR Select EC 70, a next-generation medical-grade liquid silicone rubber for wearable and diagnostic devices. The material offers high electrical conductivity, certified biocompatibility, and improved process control, advancing precision and performance in healthcare applications.

• In July 2025, Teleflex Incorporated completed the acquisition of BIOTRONIK’s Vascular Intervention business, expanding its portfolio of therapeutic and interventional access products. The deal strengthens Teleflex’s global presence in cath labs, enhances its footprint in the peripheral intervention market, and supports the distribution of products with peripheral indications.

• In May 2024, Merit Medical Systems announced FDA 510(k) clearance for its Siege vascular plug and launched the Bearing nsPVA Express prefilled syringe in the U.S. and Australia. Introduced at GEST 2024, these devices expand Merit’s embolic portfolio, complementing existing microspheres, particles, gelatin foams, and supporting microcatheters and guidewires.

• In February 2024, Terumo Medical Corporation broke ground on a new manufacturing facility in Caguas, Puerto Rico, expanding production of its Angio-Seal Vascular Closure Device. The investment responds to rising global demand, supporting rapid hemostasis, faster patient mobility, and enabling same-day discharge after angiographic or interventional procedures.

• In February 2024, Trelleborg Group, through Trelleborg Sealing Solutions, acquired Baron Group, a leading Australian-Chinese manufacturer of precision silicone components. The acquisition enhances Trelleborg’s healthcare capabilities, expanding manufacturing capacity and expertise in medical technologies, including sleep apnea, respiratory care, and COPD devices

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the medical silicone radiopaque vascular ties market based on the below-mentioned segments:

Global Medical Silicone Radiopaque Vascular Ties Market, By Type

• Occlusion Ties
• Retracting Ties
• Marking Ties

Global Medical Silicone Radiopaque Vascular Ties Market, By Application

• Cardiovascular & Thoracic Surgery

• Neurosurgery

• General Surgery

• Others

Global Medical Silicone Radiopaque Vascular Ties Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa